Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?

Tateda K, Ishii Y, Kimura S, Horikawa M, Miyairi S, Yamaguchi K.

J Infect Chemother. 2007 Dec;13(6):357-67. Review.

PMID:
18095083
2.

Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.

Tateda K, Standiford TJ, Pechere JC, Yamaguchi K.

Curr Pharm Des. 2004;10(25):3055-65. Review.

PMID:
15544497
3.
4.

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Murray TS, Egan M, Kazmierczak BI.

Curr Opin Pediatr. 2007 Feb;19(1):83-8. Review.

PMID:
17224667
5.

[Quorum sensing: the possibility of the new antibiotic target in bacterial infection].

Tomono K.

Nihon Rinsho Meneki Gakkai Kaishi. 2004 Oct;27(5):297-301. Review. Japanese.

6.
7.

Diffuse panbronchiolitis: role of macrolides in therapy.

Keicho N, Kudoh S.

Am J Respir Med. 2002;1(2):119-31. Review.

PMID:
14720066
8.

Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.

Willcox MD, Zhu H, Conibear TC, Hume EB, Givskov M, Kjelleberg S, Rice SA.

Microbiology. 2008 Aug;154(Pt 8):2184-94. doi: 10.1099/mic.0.2008/019281-0. Review.

PMID:
18667552
9.

[Foreign body infections--biofilms and quorum sensing].

Høiby N, Johansen HK, Ciofu O, Jensen PØ, Bjarnsholt T, Givskov M.

Ugeskr Laeger. 2007 Nov 26;169(48):4163-6. Review. Danish.

PMID:
18211783
10.

Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease.

Nguyen T, Louie SG, Beringer PM, Gill MA.

Curr Opin Pulm Med. 2002 Nov;8(6):521-8. Review.

PMID:
12394161
11.

Diffuse panbronchiolitis--pathophysiology and treatment mechanisms.

Yanagihara K, Kadoto J, Kohno S.

Int J Antimicrob Agents. 2001;18 Suppl 1:S83-7. Review.

PMID:
11574201
12.

The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.

Winstanley C, Fothergill JL.

FEMS Microbiol Lett. 2009 Jan;290(1):1-9. doi: 10.1111/j.1574-6968.2008.01394.x. Review.

13.

Macrolides in cystic fibrosis: is there a role?

Wolter JM, Seeney SL, McCormack JG.

Am J Respir Med. 2002;1(4):235-41. Review.

PMID:
14720043
14.

Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.

Giamarellos-Bourboulis EJ.

Int J Antimicrob Agents. 2008 Jan;31(1):12-20. Review.

PMID:
17935949
15.

Macrolides in cystic fibrosis.

McArdle JR, Talwalkar JS.

Clin Chest Med. 2007 Jun;28(2):347-60. Review.

PMID:
17467553
16.

Bacterial communications in implant infections: a target for an intelligence war.

Costerton JW, Montanaro L, Arciola CR.

Int J Artif Organs. 2007 Sep;30(9):757-63. Review.

PMID:
17918119
17.
18.

[Pathophysiology of chronic airway infections].

Kadota J.

Nihon Naika Gakkai Zasshi. 2006 Dec 10;95(12):2559-65. Review. Japanese. No abstract available.

PMID:
17240889
19.

Macrolide antibiotic therapy in patients with cystic fibrosis.

Schöni MH.

Swiss Med Wkly. 2003 May 31;133(21-22):297-301. Review.

PMID:
12861467
20.

Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.

Jakobsen TH, Bjarnsholt T, Jensen PØ, Givskov M, Høiby N.

Future Microbiol. 2013 Jul;8(7):901-21. doi: 10.2217/fmb.13.57. Review.

PMID:
23841636
Items per page

Supplemental Content

Support Center